Ocugen, Inc. (OCGN)
1.945
+0.14
(+8.06%)
USD |
NASDAQ |
Apr 15, 16:00
1.95
0.00 (0.00%)
After-Hours: 20:00
Ocugen Research and Development Expense (Annual) : 37.36M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| REGENXBIO, Inc. | 212.68M |
| Krystal Biotech, Inc. | 52.32M |
| Phathom Pharmaceuticals, Inc. | 32.78M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| MannKind Corp. | 66.35M |